- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05146544
Characteristic and Real Intensity of Exercise in a Hospital-based Physical Activity Protocol for Patients With Chronic Disease
The objective is to better characterize an adapted physical activity (APA) program within of the management of chronic diseases.
In France, since 2016, medical doctors have been able to prescribe APA to their patients with chronic diseases but while there are indeed prescription recommendations, there is no clear characterization of the practical reality of APA programs.
The interest of this work is to benefit from the experience of the Center of Sports Medicine and Adapted Physical Activities in Nancy (France) specifically dedicated to the prescription and the initiation of an APA program for of patients with a chronic disease.
Thus, this work aims to determine the real intensity of the APA, the effectiveness of the assessment necessary for the dispensation of the APA and other parameters likely to modify the result of the treatment.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Vandoeuvre les nancy, France, 54500
- Centre Hospitalier Régional Universitaire de Nancy.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- age greater than 18 years old, with the ability to perform a cardiopulmonary exercise test
Exclusion Criteria:
- beta-blocker treatment.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
No limitation of exercise performance capacities
normal maximal oxygen uptake (greater than or equal to 80% of the reference value)
|
During the APA session, HR was digitized at 1Hz (using custo guard, Custo Med GmbH).
The ratio between the APA session HR and exercise test HRpeak was used to assess the intensity of effort.
|
|
Limitation of exercise performance capacities
reduced maximal oxygen uptake (less than 80% of the reference value).
|
During the APA session, HR was digitized at 1Hz (using custo guard, Custo Med GmbH).
The ratio between the APA session HR and exercise test HRpeak was used to assess the intensity of effort.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
evaluate the real intensity level of adapted physical activity (APA).
Time Frame: Heart rate mean during 1 hour in the first APA Session (cross-sectional monocentric study)
|
evaluate the real intensity level of exercise in a sample of patients with chronic disease involved in a hospital-based program of adapted physical activity (APA).
|
Heart rate mean during 1 hour in the first APA Session (cross-sectional monocentric study)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluate Six-Minute Walk Test (6-MWT) efficacity to determine physical activity capacities
Time Frame: 6 minutes in the first APA Session (cross-sectional monocentric study)
|
evaluate Six-Minute Walk Test (6-MWT) efficacity to determine physical activity capacities for patients with chronic disease.
|
6 minutes in the first APA Session (cross-sectional monocentric study)
|
|
Evaluate sit-to-stand test (1 minute)) efficacity to determine physical activity capacities
Time Frame: 1 minute in the first APA Session (cross-sectional monocentric study)
|
Evaluate sit-to-stand test (1 minute)) efficacity to determine physical activity capacitiesfor patients with chronic disease.
|
1 minute in the first APA Session (cross-sectional monocentric study)
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2021-PI191
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.